Catalent Inc (CTLT) said Monday that it has entered a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to Ardena.
Financial details of the agreement were not disclosed. The transaction is expected to close in early 2025.
The Somerset facility also houses Catalent's corporate headquarters, which will remain through a transition period in the near term before shifting to a new location, the company said.
Price: 60.44, Change: -0.01, Percent Change: -0.02
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.